11/25
01:49 pm
drma
Dermata Therapeutics (NASDAQ:DRMA) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Dermata Therapeutics (NASDAQ:DRMA) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
9/18
09:04 am
drma
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing [Yahoo! Finance]
Medium
Report
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing [Yahoo! Finance]
9/18
08:35 am
drma
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
Low
Report
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
9/16
11:57 am
drma
Life Science Virtual Investor Forum Agenda Announced for September 18th
Medium
Report
Life Science Virtual Investor Forum Agenda Announced for September 18th
9/16
08:35 am
drma
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th
High
Report
Dermata Therapeutics to Present at the Life Sciences Virtual Investor Forum September 18th
9/10
08:28 am
drma
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments [Yahoo! Finance]
Low
Report
Dermata Therapeutics Announces Strategic Pivot to Over-the-Counter Skin Care Treatments [Yahoo! Finance]